Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.
−Removed: Cooper's common stock, par value $0.10 per share, is traded on the Nasdaq under the symbol “COO.” Prior to September 26, 2023, Cooper's common stock traded on the New York Stock Exchange under the symbol "COO".
−Removed: At December 1, 2023, there were 256 common stockholders of record.
−Removed: Dividend Policy
−Removed: In the past, we have paid annual cash dividends on our common stock of $0.06 per share, in two semiannual payments of $0.03 per share each.
−Removed: In dollar terms, we paid cash for dividends of $3.0 million in each of fiscal 2023 and 2022.
−Removed: Dividends are paid when, as and if declared at the discretion of our Board of Directors from funds legally available for that purpose.
−Removed: Our Board of Directors considers the Company's earnings, financial condition, liquidity needs, business plans and opportunities and other factors in determining whether to declare a dividend.
+Added: Our common stock, par value $0.10 per share, is traded on the Nasdaq under the symbol “COO.” As of November 29, 2024, there were 133 common stockholders of record.
In December 2023, our Board of Directors decided to end the declaration of the semiannual dividend.
+Added: We paid dividends of approximately $3.0 million in fiscal 2023.
+Added: Any future determination to pay dividends will be made at the discretion of our Board of Directors subject to applicable laws and will depend on, among other factors, our results of operations, financial condition, contractual restrictions and capital requirements.
Performance Graph
−Removed: The following graph compares the cumulative total return on Cooper's common stock with the cumulative total return of the Standard & Poor 500 and the Standard & Poor's Health Care Equipment Index for the five-year period ended October 31, 2023.
+Added: This performance graph shall not be deemed “soliciting material” or to be “filed” with the SEC for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities under that Section, and shall not be deemed to be incorporated by reference into any of our filings under the Securities Act, except as shall be expressly set forth by specific reference in such filing.
+Added: The following graph compares the cumulative total return on our common stock with the cumulative total return of the Standard & Poor 500 and the Standard & Poor's Health Care Equipment Index for the five-year period ended October 31, 2024.
The graph assumes that the value of the investment in Cooper and in each index was $100 on October 31, 2019, and assumes that all dividends were reinvested.
7 unchanged sentences
Issuer Purchases of Equity Securities
−Removed: There was no share repurchase activity during the three-month period ended October 31, 2023.
THE COOPER COMPANIES, INC.
AND SUBSIDIARIES
+Added: There was no share repurchase activity during the three-month period ended October 31, 2024.
+Added: Unregistered Sales of Equity Securities
Equity Compensation Plan Information
7 unchanged sentences
Total 5,240,679 $75.25 8,523,044
−Removed: (1) Includes (i) 290,029 shares subject to outstanding Restricted Stock Units (RSU), (ii) 138,256 shares subject to Performance Share Units (PSU), calculated at the maximum potential payout and (iii) 1,077,556 shares subject to outstanding options.
−Removed: Does not include rights to purchase shares under the 2019 Employee Stock Purchase Plan (2019 ESPP).
+Added: Above table has been adjusted to reflect the four-for-one stock split effected on February 16, 2024.
+Added: Refer to Note 1.
+Added: Organization and Significant Accounting Policies for further information
+Added: (1) Includes (i) 1,298,723 shares subject to outstanding Restricted Stock Units (RSU), (ii) 649,488 shares subject to outstanding Performance Share Units (PSU), calculated at the maximum potential payout and (iii) 3,292,468 shares subject to outstanding options.
+Added: Does not include rights to purchase shares under the 2019 Employee Stock Purchase Plan (the "2019 ESPP" or the "ESPP"), which depend on a number of factors described in the 2019 ESPP.
(2) The weighted-average exercise price is calculated based solely on the exercise prices of outstanding options and do not reflect shares to be issued upon the vesting of RSUs and PSUs, which have no exercise price.
−Removed: (3) Includes information with respect to the Third Amended and Restated 2007 Long Term Incentive Plan for Employees (2007 Plan), the 2023 Long-Term Incentive Plan (2023 Plan), which replaces the 2007 Plan, and the 2019 ESPP, as discussed in Note 9.
−Removed: Stock Plans of the Consolidated Financial Statements.
−Removed: Also includes information from the 2020 Long Term Incentive Plan for Non-Employee Directors (2020 Directors' Plan).
−Removed: As of October 31, 2023, up to 1,376,240 shares of Common Stock may be issued pursuant to the 2023 Plan, up to 921,974 s hares of Common Stock may be issued pursuant to the 2019 ESPP and up to 27,667 shares of Common Stock may be issued pursuant to the 2020 Directors' Plan.
+Added: (3) Includes (i) 4,852,018 shares available for issuance under the 2023 Plan, (ii) 3,580,869 s hares available for issuance under the 2019 ESPP and (iii) 90,157 shares available for issuance under the 2020 Long Term Incentive Plan for Non-Employee Directors.
THE COOPER COMPANIES, INC.
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.